| NDC Code | 67919-030-01 |
|---|
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (67919-030-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 67919-030 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Zerbaxa |
|---|
| Non-Proprietary Name | Ceftolozane And Tazobactam |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20141219 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA206829 |
|---|
| Manufacturer | Merck Sharp & Dohme LLC |
|---|
| Substance Name | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM |
|---|
| Strength | 1; .5 |
|---|
| Strength Unit | g/10mL; g/10mL |
|---|
| Pharmacy Classes | Cephalosporin Antibacterial [EPC], Cephalosporins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
|---|